Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viking Thera (NQ: VKTX )

50.75 +0.87 (+1.74%)
Streaming Delayed Price Updated: 12:07 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,139,863
Open 50.23
Bid (Size) 50.65 (3)
Ask (Size) 50.75 (51)
Prev. Close 49.88
Today's Range 49.87 - 51.92
52wk Range 16.70 - 99.41
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
Via The Motley Fool
After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?
Via The Motley Fool

Performance

YTD
+177.63%
+177.63%
1 Month
-21.48%
-21.48%
3 Month
-8.38%
-8.38%
6 Month
-7.74%
-7.74%
1 Year
+194.37%
+194.37%

More News

Read More
2 Disruptive Growth Stocks With Room to Run
Via The Motley Fool
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum
Via Benzinga
How Is The Market Feeling About Viking Therapeutics?
Via Benzinga
Is It Too Late to Buy Viking Therapeutics Stock?
Via The Motley Fool
Market Whales and Their Recent Bets on VKTX Options
Via Benzinga
Here's Yet Another Reason to Buy Viking Therapeutics Stock Like There's No Tomorrow
Via The Motley Fool
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
Via Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Via The Motley Fool
3 Monster Stocks in the Making
Via The Motley Fool
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
Via Investor's Business Daily
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs
Via Benzinga
Money In Motion: Top Picks To Power Your Portfolio Today
Via Talk Markets
3 Things You Need to Know if You Buy Viking Therapeutics Today
Via The Motley Fool
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.
Via The Motley Fool
Topics Government
Exposures Political
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly?
Via The Motley Fool
Is Viking Therapeutics a Buy on the Dip?
Via The Motley Fool
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
Via Investor's Business Daily
Topics Economy Government
Exposures Interest Rates Political
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move
Via The Motley Fool
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag
Via The Motley Fool
Is Viking Therepautics a Buy Now?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.